期刊文献+

促代谢型谷氨酸受体mGluR5参与膀胱的生理与伤害性感受 被引量:1

Metabotropic Glutamate Receptor 5 Contributes to Physiological and Nociceptive Sensory Processes in the Urinary Bladder
下载PDF
导出
摘要 促代谢型谷氨酸受体(mGluRs)是一类G蛋白偶联受体,参与中枢神经系统的突触可塑性和学习记忆等过程。一些研究资料表明,mGluRs还在躯体痛的外周信号转导和信号传递中起重要作用,但其在内脏感受中的作用尚不清楚。本研究的目的在于考察Ⅰ组促代谢型谷氨酸受体(mGluR5)是否参与膀胱的生理与伤害性感受。在用戊巴比妥钠(50mg/kg,ip)麻醉的大鼠,mGluR5拮抗剂MPEP(3.0mg/kgiv)能明显提高排尿反射的容积阈值,并能减弱快速充胀膀胱引起的腹肌收缩反应,提示mGluR5参与膀胱的生理和伤害性感受过程。在取自正常小鼠的膀胱/盆神经模型,MPEP(0.1 ̄100μM)对充胀膀胱引起的传入神经活动没有明显影响,而在环磷酰胺(125mg/kgip)致间质性膀胱炎(IC)的小鼠,MPEP(0.3μm)能抑制高阈值膀胱传入神经放电。在清醒、自由活动的IC小鼠,MPEP(1μmol/kg,ip)还明显抑制其后肢对机械刺激的反应。上述结果表明,mGluR5可能并不参与正常膀胱的外周机械性感受的信号转导,但可能参与膀胱生理和伤害性感受信息向脊髓和在中枢内的传递过程;外周和中枢mGluR5在实验性间质性膀胱炎时有上调现象,故可能是治疗内脏感觉过敏的一个潜在药物作用靶点。 Metabotropic glutamate receptors (mGluRs1-8) are members of the G protein-coupled receptor (GPCR) supefamily and they have been implicated in processes requiring synaptie plasticity such as learning and memory, neuronal development and neurodegeneration, mGluR5 is distributed throughout the eeatral nervous system including areas involved in nociception and in unmyelinated sensory afferent terminals as well, suggesting that mGluR may play a role in pain sensation. The present study aims to delineate the role of mGluR5 in physiological and nociceptive sensory processes of the urinary bladder, In vivo eystometry observations in the rat showed that the mGluR5 antagonist, MPEP, significantly raised the voiding threshoht, In pentobarbital-anesthetized rat, MPEP attenuated the motor responses of the abdominal muscle induced by rapid noxious distension of the urinary bladder. The effect oceurred in a dose-dependent manner and was reversible, In the isolated mouse bladder/pelvic nerve preparation, we recorded the bladder afferent nerve discharge in respnnse to nump distension of the bladder, tn preparations taken from control mice, MPEP (0.1 to 100 μM) failed to induce siguificant changes in the pressure- nerve response curve. In preparations (n=5) taken from mice pre-treated with cyclophosphamide (125 mg/kg, ip, 24 hr before experiment), MPEP (0.3 M) depressed the high threshoht afferent discharge. In in vivo studies, MPEP (1 mol/kg, ip) significantly attenuated the leg withdrawal frequency in response to yon Frey hair stimulation of the paw in cyclophophamide-treated mice but not in normal control miee. These observations indicate that mGluR5 is unlikely to be involved in peripheral mechanosensory transduction in normal bladder, but rather may play a role in central processing of the peripheral afferent inputs, Peripheral and central mGluR5 appears to be up-regulated in cyclophosphanide-induced cystitis and may therefore be potential therapeutic targets for visceral hyperalgesia and functional disorders.
出处 《科技导报》 CAS CSCD 2006年第12期23-27,共5页 Science & Technology Review
关键词 代谢型谷氨酸受体 MPEP 伤害性感受 间质性膀胱炎 内脏痛 mGluRs MPEP noeiception, interstitial cystitis visceral pain
  • 相关文献

参考文献16

  • 1KEW J N,KEMP J A.Ionotropic and metabotropic glutamate receptor structure and pharmacology[J].Psychopharmacology(Berl),2005,179:4-29.
  • 2SCHOEPP D D,JANE D E,MONN J A.Pharmacological agents acting at subtypes of metabotropic glutamate receptors[J].Neuropharmacology,1999,38:1431-1476.
  • 3PIN J P,ACHER F.The metabotropic glutamate receptors:tructure,activation mechanism and pharmacology[J].Curr.DrugTargets.CNS.Neurol.Disord.2002(1):297-317.
  • 4BORDI F,UGOLINI A.Involvement of mGluR (5) on acute nociceptive transmission[J].Brain Res,2000,871:223-233.
  • 5TZSCHENTKE T M.Glutamatergic mechanisms in different disease states:overview and therapeutical implication-an introduction[J].Amino.Acids,2002,23:147-152.
  • 6WALKER K,REEVE A,BOWES M,et al.Mglu5 receptors and nociceptive function Ⅱ:mGlu 5 receptors functionally expressed on peripheral sensory neurones mediate inflammatory hyperalgesia[J].Neuropharmacology,2001,40:10-19.
  • 7OMOTE K,KAWAMATA T,KAWAMATA M,et al.Formalininduced release of excitatory amino acids in the skin of the rat hindpaw[J].Brain Res,1998,787:161-164.
  • 8SIMMONS R M,WEBSTER A A,KALRA A B,et al.Group ⅡmGluR receptor agonists are effective in persistent and neuropathic pain models in rats[J].Pharmacol Biochem Behav.2002,73(2):419-427.
  • 9MILLS C D,JOHNSON K M,HULSEBOSCH C E.Role of group Ⅱand group Ⅲ metabotropic glutamate receptors in spinal cord injury[J].J Exp Neurol,2002,173(1):153-167.
  • 10WEIN A J,HANNO P M.Targets for therapy of the painful baldder[J].Urology,2002,59:68-73.

同被引文献24

  • 1Yin S, Niswender CM. Progress toward advanced under- standing of metabotropic glutamate receptors : structure, signaling and therapeutic indications [ J ]. Cell Signal, 2014, 26:2284-2297.
  • 2Chong ZZ, Li F, Maiese K. Group I metabotropic receptor neuroprotection requires Akt and its substrates that govern FOXO3a, Bim, and beta-catenin during oxidative stress[J]. C,rr Nurovasc Res. 2006_ 3.107-117.
  • 3Kim JH, Perry C, Luikinga S, et al. Extinction of a co- caine-taking context that protects against drug-primed rein- statement is dependent on the metabotropic glutamate [ J ].Addict Biol, 2014,9. doi: 101 lll/abd. 12142. [ Epub a- head of print].
  • 4Picker MJ, Daugherty D, Henry FE, et al. Metabotropic glutamate antagonists alone and in combination with mor- phine: comparison across two model of persistent, inflam- matory pain [ J ]. Behav Pharmacol, 2011, 22:785- 793.
  • 5Vallano A, Femandez-Duenas V, Garcia-Negredo G, et al. Targeting striatal metabotropic glutamate receptor type 5 in Parkinson's disease: bridging molecular studies and clinical trials [ J ]. CNS Neurol Disord Drug Targets, 2013, 12 :1128-1142.
  • 6Melancon B J, Tarr JC, Panarese JD, et al. Allosteric mod- ulation of the M1 muscarinic acetylcholine receptor: impro- ving cognition and a potential treatment for schizophrenia and Alzheimer's disease [ J ]. Drug Discov Today, 2013, 18:1185-1199.
  • 7Noetzel M J, Jones CK, Conn PJ. Emerging approaches for treatment of schizophrenia: modulation of glutamatergic signaling[ J]. Discov Med, 2012, 14:335-343.
  • 8Handford CE, Tan S, Lawrence A J, et al. The effect of the mGlu5 negative allosteric modulator MTEP and NMDA receptor partial agonist D-cycloserine on Pavlovian condi- tioned fear[ J ]. Int J Neuropsychopharmacol, 2014, 27 : 1-12.
  • 9Pa|ucha-Poniewiera A, Wierofaska JM, Brafaski P, et al. Is the mGlu5 receptor a possible target for new antidepres- sant drugs? [J]. Pharmacol Rep, 2013,65:1506-1511.
  • 10Palucha-Poniewiera A, Szewczyk B, Pilc A. Activation of the mTOR signaling pathway in the antidepressant-like ac- tivity of the mGlu5 antagonist MTEP and the mGlu7 ago- nist AMN082 in the FST in rats[J]. Neuropharmacology, 2014, 82:59-68.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部